Study to Evaluate the Care Process and the Quality of STEMI Care
NCT ID: NCT02961777
Last Updated: 2018-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
640 participants
OBSERVATIONAL
2014-01-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, the following objectives are set:
1. ) Study of the quality of care for patients with STEMI in 16 Flemish hospitals with cardiology department by retrospective and prospective audit of 20 patient records per participating hospital .
2. ) Study of the interdisciplinary relationships and communication within teams involved in the care of patients with STEMI in the participating hospitals 3) Study of perceived organization of care for patients with STEMI in the participating hospitals
In accordance with the objectives of the research, the study consists of three phases:
1. ) A retrospective observational audit of 20 patient records of patients with STEMI each participating hospital.
2. ) A prospective observational audit of 20 patient records of patients with STEMI each participating hospital.
3. ) A survey using validated instruments of interdisciplinary relationships and communication on the one hand and on the other by the teams involved in the care of patients with STEMI perceived organization of care .
Data collection is performed by local researchers and remains their property. The data is coded and kept confidential. Only the local researcher has access to the encryption key. The data are protected by the Belgian law on privacy and medical confidentiality, only to be used in the context of this study. The results are published anonymously.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in Belgium
NCT00727623
Impact of Ischemic Post-conditioning
NCT04068116
Quality and Safety of Initial Management for ST-segment Elevation Myocardial Infarction
NCT02788344
Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI
NCT00299377
EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocardial Infarction.
NCT03447834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Time 1
retrospective evaluation of patient record. no intervention
No interventions assigned to this group
Time 2
retrospective evaluation of patient record. no intervention
implementation of care pathway
implementation of a care pathway
Time 3
retrospective evaluation of patient record. no intervention
implementation of care pathway
implementation of a care pathway
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
implementation of care pathway
implementation of a care pathway
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* eligible for reperfusion according to ESC STEMI guidelines
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
European Pathway Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Kris Vanhaecht
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP4ACS\2013\2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.